The highly competitive Bio-Engineering Systems for Therapeutics (BEST) postdoc programme, part of the Next-gen Bioengineers initiative, is run jointly by the ETH Zurich and Roche Pharma Research and Early Development. The programme focuses on development of new tools and methods to resolve existing problems and come up with solutions for future challenges in medical translation and therapeutics.
Important hallmarks of both neurodevelopmental and neurodegenerative disorders are alterations in gene expression and the electrical properties of neurons. An important objective of this project is to link changes in neuronal functional properties to gene expression at the single cell level. We will address this question by combining single-cell electrophysiology in human neurons, using high-density microelectrode array (HD-MEA) recordings, and spatially resolved single-cell transcriptomic measurements. The developed system will be applied to advanced human cellular models of healthy and mutant neurons.
The postdoctoral researcher will be involved in the optimization of cultures of human neurons obtained via transcription factor-mediated reprogramming, the functional characterization of these cells using MEA, optical imaging based on fluorescence in situ hybridization, single-nucleus RNA-sequencing, and the analysis of the obtained data. The candidate will be part of an interdisciplinary team working on related questions at two different locations, the Department of Biosystems Science and Engineering, ETH Zürich, and the Neuroscience and Rare Disease focus area at pRED, Roche. Both Departments are located in the City of Basel. Although the focus of this position is on research, the candidate will also be involved in supervising students and some teaching activities.
We look forward to receiving your online application with the following documents as a single PDF:
Application deadline: the position is filled on a rolling basis, applications can be submitted until January 6, 2025.
Please note that we exclusively accept applications submitted through our online application portal. Applications via email or postal services will not be considered.
Questions regarding the position should be directed to [Dr. Manuel Schröter] by e-mail [manuel.schroeter@bsse.ethz.ch] and/or [Dr. Marcos R. Costa] by e-mail [marcos.costa@roche.com] (no applications).
ETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our excellent education, cutting-edge fundamental research and direct transfer of new knowledge into society. Over 30,000 people from more than 120 countries find our university to be a place that promotes independent thinking and an environment that inspires excellence.